These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 10781179

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats.
    Sugaya K, Nishijima S, Miyazato M, Ashitomi K, Hatano T, Ogawa Y.
    Neurosci Lett; 2002 Aug 02; 328(1):74-6. PubMed ID: 12123863
    [Abstract] [Full Text] [Related]

  • 7. alpha1-Adrenoceptor subtype selectivity and lower urinary tract symptoms.
    Schwinn DA, Price DT, Narayan P.
    Mayo Clin Proc; 2004 Nov 02; 79(11):1423-34. PubMed ID: 15544022
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia.
    Kojima Y, Sasaki S, Kubota Y, Imura M, Oda N, Kiniwa M, Hayashi Y, Kohri K.
    J Urol; 2011 Oct 02; 186(4):1530-6. PubMed ID: 21855934
    [Abstract] [Full Text] [Related]

  • 9. Facts and future lines of research in lower urinary tract symptoms in men and women: an overview of the role of alpha1-adrenoreceptor antagonists.
    Fitzpatrick JM.
    BJU Int; 2000 Apr 02; 85 Suppl 2():1-5. PubMed ID: 10781178
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region.
    Hennenberg M, Tamalunas A, Wang Y, Keller P, Schott M, Strittmatter F, Herlemann A, Yu Q, Rutz B, Ciotkowska A, Stief CG, Gratzke C.
    Eur J Pharmacol; 2017 May 15; 803():39-47. PubMed ID: 28315343
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Editorial comment from Dr Funahashi to α1D/A-adrenoceptor antagonist naftopidil for the male lower urinary tract symptoms associated with benign prostatic hyperplasia: efficacy of dose increase therapy.
    Funahashi Y.
    Int J Urol; 2013 May 15; 20(5):521. PubMed ID: 23131001
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.